Immunohistochemical analysis revealed that the staining of ezrin was predominantly cytoplasmic in FA (Fig. 6A), whereas both cytoplasmic and membranous staining of ezrin was observed in all thyroid carcinoma lesions except PTC indicating its translocation from cytoplasm to the membrane during cancer progression. Here, EZR is linked to thyroid gland carcinoma.